Polycystic Ovary Syndrome (PCOS): French Endocrine Society Recommendations for Diagnosis and Management

    January 2010 in “ Annales D Endocrinologie
    Didier Dewailly, S. Hieronimus, P. Mirakian, Jean-Noël Hugues
    Image of study
    TLDR The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.
    In 2010, the French Endocrine Society provided recommendations for diagnosing and managing Polycystic Ovary Syndrome (PCOS), endorsing the Rotterdam classification which requires two out of three criteria: menstrual irregularities, hyperandrogenism, and polycystic ovaries on ultrasound. The document advised against using the Ferriman-Gallway score for hirsutism diagnosis and deemed routine screening for elevated plasma LH or GnRH testing unnecessary. It emphasized systematic screening for metabolic abnormalities and recommended an oral glucose tolerance test for obese women with normal fasting serum glucose. Clomiphene citrate was recommended as the first-line therapy for ovulation induction, with lifestyle modifications advised for patients with a BMI over 30. The document also noted that a 5% reduction in baseline weight could improve pregnancy chances and that the combination of metformin with clomiphene citrate was not proven effective for all women with PCOS. Further research was suggested for the efficacy and safety of aromatase inhibitors and the value of OGTT in non-obese women with PCOS.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 93 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 2 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  443 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Bryan Johnson just dropped his anti hair loss formula

      in Treatment  339 upvotes 9 months ago
      Bryan Johnson shared his hair loss treatment, which mainly relies on minoxidil and finasteride. Some users are skeptical of his results, while others appreciate his efforts in anti-aging and hair loss research.
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 3 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

    Similar Research

    6 / 1000+ results